Entero Therapeutics - About the company
Entero Therapeutics is a public company based in Boca Raton (United States), founded in 2014. It operates as a Provider of therapeutics for the treatment of gastrointestinal health. Entero Therapeutics has raised an undisclosed amount in funding. The company has 2531 active competitors, including 857 funded and 642 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.
Company Details
Provider of therapeutics for the treatment of gastrointestinal health. It offer targeted, orally delivered therapeutics which include latiglutenase, a biotherapeutic to break up gluten and reduce celiac disease symptoms; capeserod, a selective 5-HT4 receptor partial agonist with gastrointestinal (GI) indications; and adrulipase, a recombinant lipase enzyme enable the digestion of fats and other nutrients.
- Website
- enterothera.com
- Social
- Email ID
- *****@enterothera.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2014
Location
Boca Raton, United States
Stage
Public
Latest Funding Round
Ranked
682nd among 2531 active competitors
Annual Revenue
€0 - €1M as on Dec 31, 2018
Employee Count
5 as on Jun 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Entero Therapeutics
Entero Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ENTERO CIN: 40103521749 , Latvia, Deadpooled | Mar 12, 2012 | €0 - €1M (As on Dec 31, 2018) | 2 (As on Dec 31, 2018) | - |
Entero Therapeutics's IPO details
Entero Therapeutics got listed on Oct 11, 2016.
Click here to take a look at Entero Therapeutics's IPO in detail
Sign up to download Entero Therapeutics' company profile
Entero Therapeutics's funding and investors
Entero Therapeutics has raised funding over 2 rounds. Its first funding round was on Jun 13, 2023.
Here is the list of recent funding rounds of Entero Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 14, 2023 | 1624604 | Post IPO | 4839563 | 6448015 | 8634910 | 7680000 |
Jun 13, 2023 | 2126376 | Post IPO | 4567188 | 3912781 | 8395210 | 7820299 |
Access funding benchmarks and valuations. Sign up today!View details of Entero Therapeutics's funding rounds and investors
Entero Therapeutics' founders and board of directors
Founder? Claim ProfileEntero Therapeutics' employee count trend
Entero Therapeutics has 5 employees as of Jun 26. Here is Entero Therapeutics's employee count trend over the years:
Uncover Entero Therapeutics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Entero Therapeutics's Competitors and alternates
Top competitors of Entero Therapeutics include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Entero Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 74/100 | |
3rd | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
4th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
5th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
6th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
7th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
8th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
9th |  Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 71/100 | |
10th | Celularity 2016, Warren (United States), Public | Developer of allogeneic cell therapies to treat multiple diseases | $290M | 71/100 | |
682nd |  Entero Therapeutics 2014, Boca Raton (United States), Public | Provider of therapeutics for the treatment of gastrointestinal health | - | - | 43/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Entero Therapeutics's competitors? Click here to see the top ones
Entero Therapeutics's Investments and acquisitions
Entero Therapeutics has acquired Grid AI Corp. Entero Therapeutics has not made any investments as of now.Reports related to Entero Therapeutics
Here is the latest report on Entero Therapeutics's sector:
News related to Entero Therapeutics
Filter this listMedia has covered Entero Therapeutics for a total of 8 events in the last 1 year, 4 of them have been about company updates and 1 about people movement.
•
•
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center CustomerAccess Newswire•Nov 19, 2025•Entero Therapeutics
•
•
•
•
•
•
Vicarious Surgical names Sarah Romano as CFOSeeking Alpha•Mar 13, 2025•Vicarious Surgical, Entero Therapeutics
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Entero Therapeutics
Explore our recently published companies
- Just Deploy It - Unfunded company
- American Advanced Solutions - Unfunded company
- Hughes Home Improvements - Staten Island based, Unfunded company
- Promethean General Contractors - United States based, 1980 founded, Unfunded company
- Specialty Tree Care - Baldwin Park based, Unfunded company
- 2PQ - Egypt based, Unfunded company
